AP-501
Rare Metabolic Disease
PreclinicalCandidate selection
Key Facts
Indication
Rare Metabolic Disease
Phase
Preclinical
Status
Candidate selection
Company
About Advance Pharmaceutical
Advance Pharmaceutical is dedicated to translating scientific discoveries into transformative medicines for patients with high unmet medical needs. The company's core technology enables the precise targeting of disease pathways, particularly in oncology and genetic disorders. With a robust pipeline of candidates in various stages of development and a strong leadership team, the company is strategically positioned for growth. Its focus on both internal development and strategic partnerships aims to accelerate the delivery of new therapies to market.
View full company profileTherapeutic Areas
Other Rare Metabolic Disease Drugs
| Drug | Company | Phase |
|---|---|---|
| APP-102 | Advanced Protein Production | Pre-clinical |